The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
PX-866 with Cetuximab (Erbitux) going into Phase Two
coloCan
CSN Member Posts: 1,944 Member
"PX-866 is a pan inhibitor of the PI-3K/PTEN/AKT pathway, a critical cell signalling that is activated in many types of cancer"-(CRC being one of them)
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
Its made by Oncothyreon Inc and I read about it at prenewswire.com
with an upcoming meeting of ASCO expect more in the news as drug manufacturers generally present their latest stuff at such conventions
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.7K Cancer specific
- 2.8K Anal Cancer
- 457 Bladder Cancer
- 313 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 685 Leukemia
- 805 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 243 Multiple Myeloma
- 7.2K Ovarian Cancer
- 72 Pancreatic Cancer
- 494 Peritoneal Cancer
- 5.7K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 745 Skin Cancer
- 663 Stomach Cancer
- 194 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards